We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$330M
AUM Growth
-$23.6M
Cap. Flow
-$25.7M
Cap. Flow %
-7.79%
Top 10 Hldgs %
34.6%
Holding
110
New
18
Increased
26
Reduced
40
Closed
25

Top Buys

Rank Stock Value
1
SBRA icon
Sabra Healthcare REIT
SBRA
+$12.6M
2
DHR icon
Danaher
DHR
+$11.5M
3
MD icon
Pediatrix Medical
MD
+$8.38M
4
JNJ icon
Johnson & Johnson
JNJ
+$7.49M
5
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$5.94M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$8.41M
2
UNH icon
UnitedHealth
UNH
+$6.51M
3
BCR
CR Bard Inc.
BCR
+$6.28M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$6.22M
5
TMO icon
Thermo Fisher Scientific
TMO
+$5.98M

Sector Composition

Rank Sector Weight
1 Healthcare 82.72%
2 Real Estate 3.7%
3 Financials 2.96%
4 Industrials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
26
UnitedHealth
UNH
$376B
$4.46M 1.35%
22,772
-33,712
-60% -$6.51M
VTRS icon
27
Viatris
VTRS
$20.4B
$4.12M 1.25%
131,400
-4,200
-3% -$143K
FOLD
28
CALL
DELISTED
Amicus Therapeutics
FOLD
$3.94M 1.19%
+261,000
New +$3.45M
ENTL
29
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$3.85M 1.17%
208,771
+130,171
+166% +$2.25M
HOLX
30
DELISTED
Hologic
HOLX
$3.79M 1.15%
103,203
+84,774
+460% +$3.42M
NVRO
31
DELISTED
NEVRO CORP.
NVRO
$3.59M 1.09%
39,461
-17,800
-31% -$1.52M
SYK icon
32
Stryker
SYK
$125B
$3.56M 1.08%
25,104
-37,162
-60% -$5.33M
HSIC icon
33
Henry Schein
HSIC
$9.77B
$3.44M 1.04%
+53,423
New +$3.65M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$121B
$3.33M 1.01%
+21,900
New +$3.3M
ANIP icon
35
ANI Pharmaceuticals
ANIP
$1.8B
$3.14M 0.95%
59,900
+44,300
+284% +$2.11M
CI icon
36
Cigna
CI
$73.7B
$3.12M 0.95%
16,700
+9,300
+126% +$1.66M
WAGE
37
DELISTED
WageWorks, Inc.
WAGE
$3.1M 0.94%
+51,100
New +$3.11M
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.57B
$3.05M 0.93%
+67,300
New +$2.69M
EVHC
39
DELISTED
Envision Healthcare Holdings Inc
EVHC
$3.05M 0.92%
67,860
-75,058
-53% -$4M
INSM icon
40
Insmed
INSM
$21.4B
$2.98M 0.9%
+95,400
New +$1.82M
COR icon
41
Cencora
COR
$60.6B
$2.79M 0.85%
33,740
-12,400
-27% -$1.05M
AERI
42
DELISTED
Aerie Pharmaceuticals
AERI
$2.78M 0.84%
57,188
+4,158
+8% +$227K
BDX icon
43
Becton Dickinson
BDX
$45.6B
$2.74M 0.83%
14,351
-43,358
-75% -$8.41M
JAZZ icon
44
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.7M 0.82%
18,450
-41,150
-69% -$6.22M
WBA
45
DELISTED
Walgreens Boots Alliance
WBA
$2.66M 0.81%
34,464
-13,400
-28% -$1.07M
NKTR icon
46
Nektar Therapeutics
NKTR
$2.39B
$2.62M 0.79%
7,287
+4,434
+155% +$1.39M
PBYI icon
47
Puma Biotechnology
PBYI
$404M
$2.56M 0.78%
21,400
+2,100
+11% +$195K
INCY icon
48
Incyte
INCY
$24.2B
$2.52M 0.76%
21,600
+1,400
+7% +$177K
ZTS icon
49
Zoetis
ZTS
$32.4B
$2.52M 0.76%
39,500
+24,000
+155% +$1.5M
CELG
50
DELISTED
Celgene Corp
CELG
$2.38M 0.72%
16,300
-34,900
-68% -$4.75M
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Endurant Capital Management held 110 positions worth $330M, down 6.7% from $354M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management withdrew a net $25.7M in Q3 2017, closing 25 positions and reducing 40 holdings. Its most notable exit was K2M Group Holdings, Inc, an estimated $3.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 88% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Endurant Capital Management opened a new position in Sabra Healthcare REIT worth $12.2M.

  • Endurant Capital Management's largest Q3 2017 buy was Sabra Healthcare REIT: 556,330 shares worth $12.2M.
  • Endurant Capital Management added most to Tivity Health, Inc. Common Stock in Q3 2017, an estimated $5.94M increase.
  • Endurant Capital Management's biggest Q3 2017 reduction was Becton Dickinson, cutting an estimated $8.41M.
  • Endurant Capital Management fully exited K2M Group Holdings, Inc in Q3 2017, selling an estimated $3.4M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $330M portfolio in Q3 2017.
  • Endurant Capital Management opened 18 new positions and closed 25 in Q3 2017.
  • Endurant Capital Management's portfolio value fell 6.7% quarter-over-quarter to $330M.

Based on Endurant Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.